Trial Profile
A Multicenter, Open Label, Ascending 7 Day-Repeated Dose Study to Investigate Efficacy, Safety and Pharmacokinetics of Nepadutant In Infants With Feeding Intolerance
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 May 2023
Price :
$35
*
At a glance
- Drugs Nepadutant (Primary)
- Indications Colic; Gastrointestinal disorders
- Focus Therapeutic Use
- Sponsors Menarini
- 10 Apr 2015 New trial record